Source comparison
BPC-157 vs Cortisone Heals Better — Repair vs Relief
Cortisone injections have been standard orthopedic practice for five decades. But they don't repair damaged tissue. A 2024 systematic review published in the American Journal of Sports Medicine found that cortisone injections provided short-term pain relief in
This comparison does not assign a generated winner or score.
- Cortisone injections have been standard orthopedic practice for five decades. But they don't repair damaged tissue. A 2024 systematic review published in the American Journal of Sports Medicine found that cortisone injections provided short-term pain relief in 68% of tendinopathy cases but showed no significant structural repair on follow-up MRI at 12 months. The inflammation suppression is real. The tissue healing is not. BPC-157, a pentadecapeptide derived from gastric BPC (body protection compound), operates through angiogenic and collagen-regulatory pathways that cortisone actively inhibits.
- Our team has guided researchers through peptide protocols for tendon, ligament, and muscle recovery across hundreds of studies. The gap between symptom suppression and tissue regeneration is the single most misunderstood element in injury recovery. And it defines the entire BPC-157 vs cortisone comparison.
- Does BPC-157 heal tissue faster than cortisone injections?
- BPC-157 promotes structural tissue repair by upregulating VEGF (vascular endothelial growth factor), accelerating fibroblast migration to injury sites, and stabilising collagen crosslinking during the remodeling phase. Cortisone injections suppress inflammatory cytokines (IL-1, TNF-α) to reduce pain but do not stimulate angiogenesis or collagen synthesis. Preclinical studies show BPC-157 accelerates tendon-to-bone healing by 40–60% compared to saline controls, while cortisone shows no measurable effect on structural repair markers.